Inogen, Inc. (INGN)
5.42
-0.03
(-0.55%)
USD |
NASDAQ |
Sep 04, 16:00
5.415
0.00 (0.00%)
After-Hours: 20:00
Inogen Research and Development Expense (Quarterly) : 5.871M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.871M |
| March 31, 2026 | 5.097M |
| December 31, 2025 | 5.316M |
| September 30, 2025 | 3.555M |
| June 30, 2025 | 4.00M |
| March 31, 2025 | 4.034M |
| December 31, 2024 | 5.898M |
| September 30, 2024 | 2.411M |
| June 30, 2024 | 4.428M |
| March 31, 2024 | 5.646M |
| December 31, 2023 | 6.714M |
| September 30, 2023 | 4.284M |
| June 30, 2023 | 4.293M |
| March 31, 2023 | 5.344M |
| December 31, 2022 | 5.934M |
| September 30, 2022 | 4.581M |
| June 30, 2022 | 6.064M |
| March 31, 2022 | 5.364M |
| December 31, 2021 | 4.684M |
| September 30, 2021 | 3.754M |
| June 30, 2021 | 4.123M |
| March 31, 2021 | 4.015M |
| December 31, 2020 | 3.674M |
| September 30, 2020 | 3.511M |
| June 30, 2020 | 3.29M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.605M |
| December 31, 2019 | 3.628M |
| September 30, 2019 | 2.636M |
| June 30, 2019 | 1.468M |
| March 31, 2019 | 1.669M |
| December 31, 2018 | 1.742M |
| September 30, 2018 | 2.096M |
| June 30, 2018 | 1.775M |
| March 31, 2018 | 1.416M |
| December 31, 2017 | 1.369M |
| September 30, 2017 | 1.375M |
| June 30, 2017 | 1.26M |
| March 31, 2017 | 1.309M |
| December 31, 2016 | 1.216M |
| September 30, 2016 | 1.35M |
| June 30, 2016 | 1.379M |
| March 31, 2016 | 1.168M |
| December 31, 2015 | 1.226M |
| September 30, 2015 | 1.116M |
| June 30, 2015 | 0.975M |
| March 31, 2015 | 0.863M |
| December 31, 2014 | 0.665M |
| September 30, 2014 | 0.798M |
| June 30, 2014 | 0.879M |
| March 31, 2014 | 0.635M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Inspire Medical Systems, Inc. | 24.70M |
| Enovis Corp. | 31.69M |
| Edwards Lifesciences Corp. | 278.90M |
| Intuitive Surgical, Inc. | 370.40M |
| Kewaunee Scientific Corp. | -- |